Industry: Healthcare
Published Date: April-2025
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 198
Report ID: PMRREP8419
The global on-site laboratory service market is estimated to reach a size of US$ 291.4 Bn in 2025 and is predicted to rise at a CAGR of 6.9% from 2025 to 2032. The market is likely to attain a value of US$ 464.8 Bn by 2032.
On-site laboratory service refers to the provision of laboratory services directly at the location of work or any type of commercial set-up. This type of service aims at providing on-time and accurate testing and analysis of substances/materials, which ensures adherence to safety compliance and regulations. The market encompasses a number of industries, including manufacturing, forensic, oil and gas, healthcare, environmental monitoring, pharmaceuticals, and construction.
According to Persistence Market Research, the market is driven by rising regulatory requirements, increasing focus on sustainability, and technological developments such as automation, data analytics, and portable testing equipment. On-site lab services are mainly availed by clinical diagnostics, food safety testing, environmental compliance on account of their quick and precise results, which is anticipated to drive market growth through 2032.
Key Industry Highlights:
|
Market Attributes |
Key Insights |
|
On-Site Laboratory Service Market Size (2025E) |
US$ 291.4 Bn |
|
Projected Market Value (2032F) |
US$ 464.8 Bn |
|
Global Market Growth Rate (CAGR 2025 to 2032) |
6.9% |
|
Historical Market Growth Rate (CAGR 2019 to 2024) |
6.2% |
Portable instruments enable rapid, real-time analysis, which is crucial for immediate decision-making in fields like environmental monitoring, healthcare, and food safety. This capability allows quick responses to emergencies and compliance with regulatory standards. Manufacturers invest in the development of portable, compact and user-friendly diagnostic devices of on-site testing across multiple industries, which is projected to propel the market growth during the forecast period. For instance,
Clinical laboratories are required adhere to a wide range of regulatory standards, including CLIA (Clinical Laboratory Improvement Amendments) in the U.S., ISO 15189 for medical laboratories, and FDA guidelines for medical equipment. These standards vary by region and type of testing, making compliance complex and resource-intensive. The absence of standardized regulations creates barriers for international operations. Laboratories need to comply with different standards and regulations in all countries, increasing operational costs and complexity. Such factors are projected to challenge the market growth.
Public-Private Partnerships (PPPs) are expected to help businesses bridge gaps in resources, expertise, and funding. Partnerships with public entities provide private companies access to training programs and regulatory expertise while enhancing their capacity to meet quality standards and regulatory experiments. In addition, by sharing risks with public partners, private businesses mitigate financial risks associated with large-scale investments in laboratory infrastructure. For instance,
Based on sample type, the blood & urine segment is likely to dominate and hold a share of approximately 32.4% in 2025. The dominance of the segment is expected to be largely due to increasing prevalence of chronic diseases that is driving the demand for blood & urine tests globally. This test is essential for early detection and management of diseases such as diabetes, cardio-vascular diseases, and others. Besides, the rising geriatric population is leading to a continual need for health monitoring and diagnosis, which is anticipated to favor growth of the segment. For instance,
On the basis of mode of operation, the automated testing segment is anticipated to hold a share of 26.5% in 2025. Automated testing is widely preferred in the healthcare settings to its ability to provide accurate and consistent results, particularly in the areas such as high-throughput screening and minimizing human error. Moreover, automated systems streamline repetitive tasks and enable labs to process more samples and tests in less time. Overall, the high demand for automation in testing is likely to favor positive growth in the forthcoming years.
North America is likely to dominate and account for 38.5% market share in 2025. Presence of a robust healthcare infrastructure in this region, particularly the United States, supports the integration of on-site laboratory services to enhance patient care through rapid diagnostics. The U.S. companies focus on expanding their manufacturing capabilities to cater to the rising demand for accurate testing results.
For example, in October 2024, Torrent Laboratory, California’s premier environmental testing provider, announced its expansion in Alaska. The company plans to set up a new 20,000 sq.ft state-of-the-art testing facility to offer its signature advanced testing methods such as soil and water testing, soil vapor monitoring and testing, dioxin and furan testing, and others.
Such initiatives, led with high demand for rapid, accurate, and accessible testing solutions is anticipated to drive the growth in the U.S. during the forecast period.
Europe is likely to hold a market share of about 31.6% in 2025 and is expected to showcase considerable growth in the forthcoming years. In Europe, the primary focus is to ensure agriculture sustainability by balancing three fundamental components, i.e., environmental health, economic profitability, and social and economic equity. The European Union's stringent regulations on food quality and environmental protection drive the demand for agricultural testing services. This includes regular testing for soil health, water quality, and crop contaminants, which on-site laboratories can provide efficiently.
The integration of precision farming techniques, which rely heavily on on-site testing data helps farmers optimize crop yields while minimizing environmental impact. This approach supports the adoption of on-site laboratory services to ensure compliance with EU regulations and enhance sustainability. Owing to the high demand for testing services from the agriculture industry in Europe, the regional companies are focusing on collaboration, partnerships, and product innovation strategies to gain a strong foothold. For instance,
Asia Pacific is anticipated to witness a substantial growth during the forecast period driven by factors such as increasing investments in healthcare sector and expanding pharmaceutical and biotech industries. Further, governments are implementing policies that support private investments in healthcare, with significant growth opportunities and ease of business for the companies. The increasing private investments is expected to boost infrastructure development, promote technological advancements, and forge strategic partnerships supporting the on-site laboratory service market growth.
The global market is supported by the presence of large multinational companies and specialized service providers. These companies adopt strategies such as collaboration, mergers and acquisitions, and investments in research and development activities to gain a stronghold in the market.
Companies are investing in advanced technologies such as automation and AI to improve their overall operational efficiency and differentiate themselves from the competition. Factors such as the rising demand for rapid testing and increasing focus on environmental regulations are likely to propel the companies to adapt quickly to technological and regulatory requirements to maintain dominance.
|
Attributes |
Details |
|
Forecast Period |
2025 to 2032 |
|
Historical Data Available for |
2019 to 2024 |
|
Market Analysis |
US$ Billion for Value |
|
Key Regions Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled in the Report |
|
|
Report Coverage |
|
|
Customization and Pricing |
Available upon request |
By Sample Type
By Mode of Operation
By End-Use
By Region
To know more about delivery timeline for this report Contact Sales
The market size is set to reach US$ 291.4 Bn in 2025.
The industry is expected to be valued at US$ 464.8 Bn in 2032.
A few of the leading players in the market are Abbott Laboratories, Quest Diagnostics, Eurofins Scientific, SGS Group, Bureau Veritas, ALS Limited, and Intertek Group.
The industry is estimated to rise at a CAGR of 6.9% during the forecast period.
North America is expected to capture the largest share of about 38.5% in 2025.
